Marilena Bohley Steiger, research group leader in the Drug Formulation and Delivery Laboratory (Leroux Group) at ETH Zurich, has been awarded the Galenus Technology Prize 2025 for her research on enzyme-mediated absorption enhancement for non-invasive drug delivery.
Artificial intelligence predicts how the gene-editing tool CRISPR works – making the technology now safer. The new method was developed by a team led by Soeren Lienkamp, professor at the University of Zurich and ETH Zurich.
The HistoPlexer deep learning model can predict multiple protein markers from standard tissue images. This makes a key step in cancer research faster, more accessible, and more affordable than current approaches. In this interview, ETH researcher Sonali Andani explains how it works and what it could mean for the future of cancer diagnostics.